Luminist Labs

YCW16

Diagnostic platform for early detection of liver disease

—

/ 100

О компании

Luminist developed a non-invasive diagnostic test for the early detection and staging of liver fibrosis and non-alcoholic steatohepatitis (NASH). Luminist was acquired in 2020 by DiscernDx.

Команда

2 чел.

Статус

Acquired

Открыть в YC →Сайт компании →

Подробнее о методологии скоринга →